# Brooklyn ImmunoTherapeutics LLC

Brooklyn ImmunoTherapeutics LLC is an Asset Manager based in New York, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Assets under management:** Undisclosed
- **LinkedIn:** https://www.linkedin.com/company/brooklyn-immunotherapeutics

## Regulatory record

- **Reports private funds:** No

## About

Brooklyn ImmunoTherapeutics LLC is a New York-based entity with a name implying a focus on immunotherapeutics, a class of treatments that harness the immune system to fight disease. The firm's founding year, leadership team, and wealth origin are not publicly documented. This lack of disclosure places it among opaque entities in the healthcare investment space. The firm's specific asset-class mix, stage preferences, and geographic footprint are unknown. No named portfolio companies, deals, or co-investors have been publicly reported. Without public filings or press releases, its operational posture is unverifiable. Team size and additional offices are not confirmed. No adjacent vehicles, such as foundations or operating companies, have been linked to the entity. Recent public activity is absent, with no dated events in the last 24 months. The firm's structural differentiator, if any, is unclear. Its obscurity may indicate a very small scale, a non-public investment vehicle, or a dormant status. Public records offer no insight into its governance, succession, or regulatory posture.

## Sectors

- Healthcare Services
- Therapeutics
- Biotechnology

## Questions

### Who leads investment decisions at the firm?

The firm does not publicly disclose its leadership or investment committee. No named principals or decision-makers are recorded in public records or press releases.

### Does the firm make direct investments or fund commitments?

No public information exists on the firm's investment vehicles or strategies. It is unknown whether it participates in direct deals, fund commitments, or co-investments.

### Where does the underlying capital come from?

The wealth origin or sources of capital for this entity are not disclosed. No public documents link it to a specific family, endowment, or institutional pool.

## Related profiles

- [NMotion](https://altss.com/profile/nmotion)
- [PlumRiver LLC](https://altss.com/profile/plumriver-llc)

---

Updated: 2026-08-10T19:36:47.593Z

Canonical page: https://altss.com/profile/brooklyn-immunotherapeutics-llc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology